Retour sur lavenir.net
   NYXOAH 1.252 € (+0,97 %)     RETAIL ESTATES 65.700 € (-0,30 %)     AGFA-GEVAERT 0.370 € (-0,27 %)     ABO GROUP 3.800 € (+1,60 %)     GIMV 44.550 € (-0,45 %)     TINC 11.440 € (+1,24 %)     CAMPINE 210.000 € (+1,45 %)     BEKAERT 41.450 € (-1,43 %)     RECTICEL 11.940 € (+0,34 %)     ONTEX GROUP 2.250 € (+2,74 %)     UMICORE 20.060 € (-1,08 %)     TUBIZE-FIN 209.800 € (0,00 %)     TESSENDERLO 20.550 € (-1,20 %)     CENERGY 20.760 € (-1,05 %)     EVS 27.400 € (+1,29 %)     AEDIFICA 70.600 € (+0,79 %)     ELIA GROUP 136.000 € (-1,81 %)     KBC ANCORA 87.100 € (-0,46 %)     BPOST 1.516 € (-0,13 %)     TITAN S.A. 51.500 € (+2,08 %)     FAGRON 23.150 € (-0,43 %)     VAN DE VELDE 29.700 € (-0,34 %)     DECEUNINCK 2.230 € (+4,45 %)     AGEAS 71.400 € (-0,35 %)     D'IETEREN GROUP 178.300 € (+2,00 %)     ECONOCOM GROUP 1.380 € (-2,13 %)     KINEPOLIS GROUP 39.600 € (+3,94 %)     WERELDHAVE BELGIUM 53.400 € (0,00 %)     GBL 77.750 € (-0,89 %)     VGP 84.500 € (+0,12 %)     AZELIS GROUP 10.560 € (-0,56 %)     ARGENX SE 789.800 € (-1,82 %)     CARE PROPERTY INV. 12.740 € (+0,47 %)     FLUXYS BELGIUM D 19.450 € (-2,75 %)     SHURGARD 25.900 € (+1,37 %)     CMB.TECH 13.460 € (-2,89 %)     MELEXIS 68.650 € (-2,83 %)     ACCENTIS 0.026 € (+4,00 %)     ACKERMANS V.HAAREN 263.000 € (-1,05 %)     AB INBEV 71.120 € (-0,73 %)     SOLVAY 26.220 € (-0,76 %)     SYENSQO 70.450 € (-0,84 %)     PROXIMUS 6.170 € (+0,90 %)     SOFINA 238.000 € (0,00 %)     UCB 245.800 € (-0,08 %)     IBA 16.220 € (-1,22 %)     XIOR 27.700 € (+0,18 %)     DEME GROUP 165.600 € (-1,43 %)     HOME INVEST BE. 19.900 € (+0,10 %)     ASCENCIO 52.400 € (+0,19 %)     JENSEN-GROUP 84.000 € (-0,47 %)     KBC 122.750 € (+0,29 %)     CFE 12.100 € (0,00 %)     LOTUS BAKERIES 10 700.000 € (-0,19 %)     ONWARD MEDICAL 2.405 € (0,00 %)     VASTNED 29.250 € (-0,85 %)     SIPEF 92.400 € (-0,75 %)     WDP 22.640 € (+2,26 %)     BARCO 8.010 € (+0,75 %)     BREDERODE 103.000 € (+0,59 %)  
   SOPRA STERIA GROUP 164.800 € (+6,39 %)     SANOFI 77.790 € (+2,31 %)     L'OREAL 375.550 € (+0,23 %)     ASML HOLDING 1 429.800 € (-8,42 %)     RENAULT 26.500 € (+1,38 %)     BE SEMICONDUCTOR 205.100 € (-9,65 %)     WOLTERS KLUWER 67.360 € (+7,85 %)     ALSTOM 16.210 € (+1,25 %)     IMMOB.DASSAULT 45.900 € (-1,71 %)     ORANGE 16.415 € (+1,58 %)     ARCADIS 41.600 € (+0,48 %)     LVMH 466.800 € (+1,10 %)     SHELL PLC 38.335 € (-1,13 %)     AIR LIQUIDE 177.180 € (+0,37 %)     TKH GROUP 42.420 € (-1,30 %)     IPSOS 40.360 € (+0,65 %)     INNELEC MULTIMEDIA 2.760 € (-1,78 %)     SIRIUS MEDIA 0.650 € (+14,86 %)     RELX 31.520 € (+4,79 %)     ADYEN 835.800 € (+4,34 %)     LISI 65.800 € (-1,64 %)     GROUPE OKWIND 0.338 € (+27,55 %)     ASM INTERNATIONAL 798.400 € (-7,10 %)     EUROPLASMA 0.001 € (0,00 %)     ENGIE 27.000 € (-2,84 %)     HAFFNER ENERGY 0.255 € (+16,17 %)     MEDINCELL 26.000 € (0,00 %)     KAUFMAN ET BROAD 25.400 € (-2,12 %)     FERRARI GROUP 7.840 € (+2,22 %)     Vusion 131.000 € (+0,85 %)     CARREFOUR 16.090 € (+2,45 %)     SCHNEIDER ELECTRIC 265.600 € (-0,91 %)     CAPGEMINI 95.120 € (+5,83 %)     SOCIETE GENERALE 78.090 € (+1,19 %)     TOTALENERGIES 74.380 € (-2,00 %)     ALFEN 12.650 € (-1,94 %)     ECOMIAM 1.875 € (-8,54 %)     AMG 27.080 € (+1,50 %)     SENSORION 0.295 € (+8,47 %)     STMICROELECTRONICS 45.885 € (-1,88 %)     ATOS GROUP 30.760 € (+2,26 %)     WATERA 1.050 € (-6,67 %)     EKINOPS 2.530 € (+2,02 %)     GECINA 74.750 € (+1,01 %)     FUGRO 9.500 € (-2,16 %)     BASIC-FIT 32.040 € (-0,25 %)     PHILIPS KON 23.530 € (+1,60 %)     KPN KON 4.154 € (+1,29 %)     KLARSEN 0.900 € (+60,71 %)     ING GROEP N.V. 29.280 € (+1,14 %)     FORVIA 8.708 € (-0,32 %)     ASR NEDERLAND 70.060 € (+0,14 %)     EDENRED 26.930 € (+1,97 %)     AB SCIENCE 0.698 € (+36,59 %)     BAM GROEP KON 10.850 € (-1,36 %)     FASTNED 31.850 € (-0,47 %)     TETRAGON FIN GRP 13.700 € (-0,36 %)     CSG 16.260 € (+4,81 %)     ARCELORMITTAL SA 58.160 € (-1,32 %)     PROSUS 37.850 € (+2,98 %)  
News Réglementées
12/01/2023 14:20

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

The Vanguard Group, Inc. ( IRSH)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

12-Jan-2023 / 13:20 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

(a) Full name of discloser:

The Vanguard Group, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

Horizon Therapeutics plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

10 January 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) (Note 2)

 

Class of relevant security:

(Note 3)

$0.0001 ordinary shares

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

21,220,811

9.36%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 TOTAL:

21,220,811

9.36%

 

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

 

 

 

 

 

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

(Note 5)

$0.0001 ordinary shares

Purchase

1,369

113.06 USD

$0.0001 ordinary shares

Sale

551

113.06 USD

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

(Note 6)

Price per unit

(Note 5)

Not Applicable

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

(Note 6)

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Not Applicable

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(Note 5)

Not Applicable

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities) (Note 3)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

(Note 5)

Not Applicable

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

12 Janua

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière